Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Masa Nakatsu
AddedFeb 17, 2024
UpdatedMay 31, 2026
Masa Nakatsu

Masa Nakatsu

Founder, Windtree Therapeutics

CrunchbaseLinkedIn

Masa Nakatsu's Career

Windtree Therapeutics
Windtree Therapeutics

Warrington, PA, US

Founder
Orb Labs
Orb Labs

Manhattan Park, NY, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Masa Nakatsu's Career

Windtree Therapeutics
Windtree Therapeutics
Public$138.9M331992Warrington, PA, US
Founder

Leadership at Windtree Therapeutics

Rob ScottRob ScottBoard Member
James HuangJames HuangBoard Member
Leslie J WilliamsLeslie J WilliamsBoard Member
Dan GeffkenDan GeffkenBoard Member
Craig E FraserCraig E FraserBoard Member

Similar to Windtree Therapeutics

PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
PineTree TherapeuticsPineTree TherapeuticsCambridge, MA, USBiotech Therapiesest. 2019PineTree TherapeuticsCambridge, MA, US · est. 2019

PineTree Therapeutics: Innovating biotech therapies in Oncology and Immuno-oncology.

Series B · $23.5M17
Windgap MedicalWindgap MedicalWatertown, MA, USHealthcare Productsest. 2011Windgap MedicalWatertown, MA, US · est. 2011

Windgap Medical, Inc.: Biotech firm specializing in allergy treatment healthcare products.

Public · $42M47
Window TherapeuticsWindow TherapeuticsBoston, MA, USCancer Treatmentest. 2021Window TherapeuticsBoston, MA, US · est. 2021

Window Therapeutics: A biotech firm innovating targeted cancer treatments for unmet patient needs.

Angel · $256k4
Orb Labs
Orb Labs
Investment FirmInvestment Firm$4.5M42022Manhattan Park, NY, US
Founder

Similar to Orb Labs

OrbOrbSan Francisco, CA, USest. 2022OrbSan Francisco, CA, US · est. 2022

Orb: A decentralized social media platform, crafting on-chain experiences for seamless access to the next-gen internet.

Investment Firm · $2.3M16
OrbsOrbsTel Aviv, Tel Aviv District, ILest. 2017OrbsTel Aviv, Tel Aviv District, IL · est. 2017

Orbs: Providing Blockchain Infrastructure as a Service for established consumer brands.

Investment Firm · $128M44
AstrolabAstrolabFinland, MN, USest. 2021AstrolabFinland, MN, US · est. 2021

Astrolab optimizes investments via AI, directing funds to top pools on compatible chains, saving time and money.

Investment Firm · $5M50
LayerZero LabsLayerZero LabsVancouver, British Columbia, CAest. 2021LayerZero LabsVancouver, British Columbia, CA · est. 2021

LayerZero Labs: Developing blockchain messaging protocols for decentralized applications across multiple chains.

Investment Firm · $293.3M83

Masa Nakatsu's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuChi-hyung SongChi-hyung SongCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver Financial

People Similar to Masa Nakatsu

Jason AndrewsJason AndrewsCo-Founder & CEO · OrbitePatrick WoodsPatrick WoodsCo-Founder · OrbitTal KolTal KolCo-Founder · OrbsNetta KorinNetta KorinCo-Founder · Orbs